A major advance in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This crucial malignant inhibitor protein is frequently inactivated in various forms of cancer, causing uncontrolled https://ztndz.com/story29823244/mini-antibodies-revive-the-p53-protein-a-new-pathway-for-malignant-management